7/8, 11:17 PM (Source: TeleTrader)
more TeleTrader news

Pfizer to develop booster jab for COVID Delta variant

Pfizer Inc. and BioNTech SE announced that they are in the process of developing a booster shot for their coronavirus vaccine that will specifically target the Delta variant of the virus.

The companies noted that they remain certain that a third jab of their existing vaccine would be enough to provide extra protection against the Delta variant, but stated that they are developing an updated version of the vaccine just for that variant in order to "remain vigilant."

Lastly, the pharmaceutical firms said that, following real-world evidence released by Israeli health authorities, vaccine efficacy declines after six months. Therefore, they concluded that, based on the current data, a third dose may be needed "within six to 12 months after full vaccination."

Breaking the News / OL